Honestly, I don't know enough about any correlation or relationship between the personality of a CEO and the share price. I was in sales at AT&T for a while, and even though I hated every minute, I do know how important sales/marketing can be. However and obviously, there's a world of difference bwteen a Dow 30 company and a start-up biotech, so...in my limited experience, I think we first need a very steady, informed, and rock-solid individual in the wild-west biotech start up sector. Anything less could do irreperable harm to a company's rep.
But now that we have achieved a growing/reliable revenue stream without ANY bad news for quite a long time, I think we're well positioned for the kind of growth that we all have expected for a long, very long time.
Oh, and before I forget, thanks, coldterd, for your advice about 2 months ago on another small biotech. I still have my CTSO, but I have finally diversified into a SECOND stock. Yep, a veritible mutual fund of - 2 - stocks.
Go CTSO!